A detailed history of Price T Rowe Associates Inc transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 568,894 shares of AMPH stock, worth $25.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
568,894
Previous 583,906 2.57%
Holding current value
$25.1 Million
Previous $23.4 Million 18.2%
% of portfolio
0.0%
Previous 0.0%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$36.99 - $50.09 $555,293 - $751,951
-15,012 Reduced 2.57%
568,894 $27.6 Million
Q2 2024

Aug 14, 2024

SELL
$38.65 - $43.48 $24,658 - $27,740
-638 Reduced 0.11%
583,906 $23.4 Million
Q1 2024

May 15, 2024

SELL
$42.85 - $63.45 $103,397 - $153,104
-2,413 Reduced 0.41%
584,544 $25.7 Million
Q4 2023

Feb 14, 2024

BUY
$44.49 - $62.93 $767,230 - $1.09 Million
17,245 Added 3.03%
586,957 $36.3 Million
Q3 2023

Nov 14, 2023

BUY
$45.51 - $65.0 $2.89 Million - $4.12 Million
63,404 Added 12.52%
569,712 $26.2 Million
Q2 2023

Aug 14, 2023

BUY
$35.77 - $58.38 $1.36 Million - $2.21 Million
37,888 Added 8.09%
506,308 $29.1 Million
Q1 2023

May 15, 2023

SELL
$27.99 - $37.92 $8.98 Million - $12.2 Million
-320,750 Reduced 40.64%
468,420 $17.6 Million
Q4 2022

Feb 14, 2023

SELL
$27.93 - $31.27 $546,338 - $611,672
-19,561 Reduced 2.42%
789,170 $22.1 Million
Q3 2022

Nov 14, 2022

BUY
$27.56 - $37.75 $17.8 Million - $24.4 Million
645,917 Added 396.72%
808,731 $22.7 Million
Q2 2022

Aug 15, 2022

BUY
$29.79 - $42.29 $4.85 Million - $6.89 Million
162,814 New
162,814 $5.66 Million

Others Institutions Holding AMPH

About Amphastar Pharmaceuticals, Inc.


  • Ticker AMPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,015,200
  • Market Cap $2.16B
  • Description
  • Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...
More about AMPH
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.